Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Biotech Gwth (BIOG) Share Price

Price 1,394.00p on 29-10-2026 at 09:55:14
Change 14.00p 1.01%
Buy 1,406.00p
Sell 1,384.00p
Last Trade: Buy 2,148.00 at 1,396.2807p
Day's Volume: 12,068
Last Close: 1,380.00p
Open: 1,398.00p
ISIN: GB0000385517
Day's Range 1,394.00p - 1,402.00p
52wk Range: 1,055.00p - 1,786.00p
Market Capitalisation: £256.84m
VWAP: 1,394.28758p
Shares in Issue: 18.42m

Biotech Gwth (BIOG) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 2,148 1,396.2807p Ordinary
09:55:07 - 29-Oct-26
Buy* 71 1,399.52p Ordinary
09:42:48 - 29-Oct-26
Buy* 150 1,398.0749p Ordinary
09:41:35 - 29-Oct-26
Buy* 500 1,398.0569p Ordinary
09:37:52 - 29-Oct-26
Sell* 559 1,387.096p Ordinary
09:26:08 - 29-Oct-26
Buy* 354 1,401.658p Ordinary
09:25:22 - 29-Oct-26
Buy* 49 1,401.686p Ordinary
09:25:06 - 29-Oct-26
Sell* 300 1,394.00p Automatic Execution
09:05:51 - 29-Oct-26
Sell* 150 1,396.00p Automatic Execution
09:05:51 - 29-Oct-26
Buy* 354 1,402.00p Ordinary
08:50:44 - 29-Oct-26
See more Biotech Gwth trades

Biotech Gwth (BIOG) Share Price History

Time period:
to
Date Open High Low Close Volume
29th Oct 2026 (Thu) 1,398.00 1,402.00 1,394.00 1,380.00 12,068
28th Oct 2026 (Wed) 1,376.00 1,390.00 1,370.00 1,380.00 61,149
27th Oct 2026 (Tue) 1,326.00 1,372.00 1,326.00 1,372.00 57,151
26th Oct 2026 (Mon) 1,330.00 1,354.00 1,330.00 1,336.00 57,181
23rd Oct 2026 (Fri) 1,340.00 1,354.00 1,334.00 1,342.00 67,580
22nd Oct 2026 (Thu) 1,336.00 1,362.00 1,336.00 1,360.00 113,783
21st Oct 2026 (Wed) 1,376.00 1,384.00 1,360.00 1,376.00 153,029
20th Oct 2026 (Tue) 1,300.00 1,376.00 1,296.00 1,370.00 130,401
19th Oct 2026 (Mon) 1,326.00 1,334.00 1,308.00 1,332.00 89,152
16th Oct 2026 (Fri) 1,374.00 1,374.00 1,324.00 1,324.00 19,731
15th Oct 2026 (Thu) 1,332.00 1,382.00 1,332.00 1,382.00 56,632
14th Oct 2026 (Wed) 1,354.00 1,358.00 1,334.00 1,358.00 62,941
13th Oct 2026 (Tue) 1,394.00 1,402.00 1,350.00 1,356.00 76,169
12th Oct 2026 (Mon) 1,400.00 1,406.00 1,396.00 1,406.00 36,780
9th Oct 2026 (Fri) 1,380.00 1,410.00 1,372.00 1,400.00 73,747
8th Oct 2026 (Thu) 1,420.00 1,420.00 1,348.00 1,364.00 113,932
7th Oct 2026 (Wed) 1,422.00 1,432.00 1,412.00 1,430.00 173,357
6th Oct 2026 (Tue) 1,456.00 1,466.00 1,420.00 1,448.00 50,320
5th Oct 2026 (Mon) 1,484.00 1,484.00 1,440.00 1,452.00 83,730
2nd Oct 2026 (Fri) 1,500.00 1,500.00 1,466.00 1,482.00 131,874
1st Oct 2026 (Thu) 1,526.00 1,532.00 1,500.00 1,500.00 32,795
30th Sep 2026 (Wed) 1,512.00 1,548.00 1,510.00 1,548.00 61,765
29th Sep 2026 (Tue) 1,534.00 1,556.00 1,510.00 1,510.00 53,608
See more Biotech Gwth price history

Biotech Gwth (BIOG) Regulatory News

Date Source Headline
28th Oct 2026 1:21 pm PRN Net Asset Value(s)
27th Oct 2026 1:42 pm PRN Net Asset Value(s)
26th Oct 2026 12:55 pm PRN Net Asset Value(s)
23rd Oct 2026 5:25 pm PRN Transaction in Own Shares
23rd Oct 2026 2:59 pm PRN Net Asset Value(s)
22nd Oct 2026 2:39 pm PRN Net Asset Value(s)
21st Oct 2026 2:49 pm PRN Net Asset Value(s)
20th Oct 2026 2:10 pm PRN Net Asset Value(s)
19th Oct 2026 2:49 pm PRN Net Asset Value(s)
16th Oct 2026 5:24 pm PRN Transaction in Own Shares
See more Biotech Gwth regulatory news

Biotech Gwth (BIOG) Share News

EARNINGS AND TRADING: Allergy Therapeutics names next executive chair

28th Jul 2026 13:36

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Biotech Growth says AtaiBeckley set for Eli Lilly takeover

17th Jul 2026 14:31

Biotech Growth Trust PLC - London-based investment trust - Eli Lilly & Co intends to acquire portfolio company AtaiBeckley Inc for approximately USD2.8 billion, or USD6.75 per share, in cash. This represents a 26% premium to AtaiBeckley's closing price on Wednesday. The offer also includes up to USD1 billion in contingent value rights linked to development and regulatory milestones, taking the potential value to USD3.8 billion, or USD9.25 per share, a 73% premium. AtaiBeckley is a clinical-stage biotechnology company focused on developing drugs to treat psychiatric disorders. BIOG says its AtaiBeckley holding accounted for 1.1% of its net asset value at the time of the announcement, and the transaction will be reflected in its Thursday NAV. Says this deal is the latest in a series of successful portfolio takeovers this year. Most recently, in May, French private equity firm ArchiMed SAS agreed to acquire investee Esperion Therapeutics. Read More

LONDON BRIEFING: Burberry US sales boost turnaround; Wise revenue up

17th Jul 2026 07:53

(Alliance News) - Burberry returns to first-quarter sales growth and raises its wholesale revenue guidance. Read More

EARNINGS AND TRADING: Vaultz Capital ousts CEO Benz, promotes Wood

3rd Jun 2026 19:08

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Apellis investors respond to USD5.60 billion Biogen acquisition

1st Apr 2026 16:17

(Alliance News) - Biotech Growth Trust PLC, International Biotechnology Trust PLC, ad RTW Biotech Opportunities Ltd have all noted the agreement announced by Biogen Inc on Tuesday to acquire Apellis Pharmaceuticals, Inc. Read More

See more Biotech Gwth news
FTSE 100 Latest
Value10,731.43
Change36.93

Login to your account

Forgot Password?

Not Registered